Aydin Ufuk, Gorur Alper, Findik Orhan, Yildirim Abdullah, Kocogullari Cevdet Ugur
Department of Cardiovascular Surgery, Kocaeli Derince Training and Research Hospital, Kocaeli, Turkey
Department of Cardiovascular Surgery, Kocaeli Derince Training and Research Hospital, Kocaeli, Turkey.
Vascular. 2015 Feb;23(1):41-6. doi: 10.1177/1708538114529950. Epub 2014 Mar 27.
Lymphatic complications, lymphocele and lymphorrhea being the leading, are generally encountered after vascular interventions and surgeries. The present study aimed to evaluate the outcomes of vacuum-assisted-closure (VAC) therapy, which we frequently prefer as the first-choice treatment for such complications.
Among patients undergoing peripheral vascular intervention or surgery between January 2008 and February 2012, the medical files of 21 patients who received VAC therapy or other treatment due to symptomatic lymphatic complications were retrospectively analyzed and the results were discussed.
Group I consisted of 10 patients (three with lymphocele and seven with lymphorrhea) who underwent VAC therapy as the first-choice treatment, Group II consisted of 11 patients of which 7 patients received various therapies before VAC therapy and 4 patients received other treatments alone. The patients who received VAC therapy as the primary therapy demonstrated more rapid wound healing, early drainage control, and shorter hospital stay. The mean hospital medical cost was €1038 (range, €739-1826) for the patients who primarily underwent VAC therapy; it was calculated to be €2137 (range, €1610-3130) for the other patients (p=0.001).
In addition to its safety and good clinical outcomes, VAC therapy also has economic advantages and should be the primary method for the treatment of lymphatic complications.
血管介入治疗和手术后常见淋巴并发症，其中淋巴管瘤和淋巴漏最为主要。本研究旨在评估负压封闭引流（VAC）疗法的效果，我们经常将其作为此类并发症的首选治疗方法。
回顾性分析2008年1月至2012年2月期间接受外周血管介入治疗或手术的患者中，因有症状的淋巴并发症接受VAC治疗或其他治疗的21例患者的病历，并讨论结果。
第一组由10例患者组成（3例淋巴管瘤患者和7例淋巴漏患者），他们接受VAC治疗作为首选治疗方法；第二组由11例患者组成，其中7例患者在接受VAC治疗前接受了各种治疗，4例患者仅接受了其他治疗。作为主要治疗方法接受VAC治疗的患者伤口愈合更快，引流控制更早，住院时间更短。主要接受VAC治疗的患者平均住院医疗费用为1038欧元（范围为739 - 1826欧元）；其他患者的平均住院医疗费用计算为2137欧元（范围为1610 - 3130欧元）（p = 0.001）。
VAC疗法除了具有安全性和良好的临床效果外，还具有经济优势，应作为治疗淋巴并发症的主要方法。
